HemoCue America Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • HemoCue America's estimated annual revenue is currently $19.3M per year.(i)
  • HemoCue America's estimated revenue per employee is $251,000

Employee Data

  • HemoCue America has 77 Employees.(i)
  • HemoCue America grew their employee count by 1% last year.

HemoCue America's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is HemoCue America?

HemoCue America is the U.S. arm of Sweden-based HemoCue AB. HemoCue has been a pioneer in point-of-care diagnostic testing since 1982. Our systems provide health care professionals with rapid lab-quality results, so you can go from assessment to treatment in minutes. Designed with our proven, reliable microcuvette technology, our hematology and diabetes management systems allow for fast and easy tests that can be performed with minimal training and maintenance. Our product lineup includes: - Hematology Systems - Diabetes Management - Centrifuges - Rapid Diagnostics Please visit our website for more details.

keywords:N/A

N/A

Total Funding

77

Number of Employees

$19.3M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

HemoCue America News

2022-04-20 - Hematological Cancers Market Size, Outlook And Forecast ...

... Kite Pharma, Celgene Corporation, Abbott Laboratories, Beckman Coulter, HemoCue AB ... Latin America (Brazil, Mexico, and the rest of Latin America)

2022-04-17 - Point Of Care Data Management Systems Market – Major ...

Siemens, HemoCue, Abbott, Radiometer Medical, Telcor, Thermo Fisher Scientific · North America (U.S. · Europe (Germany, United Kingdom, France,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.6M78-11%N/A
#2
$19.6M800%N/A
#3
$19.4M813%N/A
#4
$24.7M81-6%N/A
#5
$11.9M820%N/A